pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of hematological tumors and solid cancers, and pharmaceutical preparations for the treatment of inflammatory diseases, including autoimmune diseases, immune dysregulation and transplant-related diseases, particularly monoclonal antibodies for treatment of these diseases